DEA DIVERSION Scandal Exposed - Marijuana Drug Development Obstruction
DEA Back to Training School, DEA Bureaucrat Blocks Science While Ignoring their Own TRAINING Manual.
DEA Assistant Administrators and attorney needs a summer assignment, and MMJ BioPharma Cultivation has a suggestion: go back and read your own policy statement and training manual.
WASHINGTON, DC, June 10, 2025 (Newswire.com) - The DEA Diversion division cast of clowns needs a summer assignment and MMJ BioPharma Cultivation has a suggestion: go back and read your own mission statement and training manual.
For years, the DEA DEPUTY Administrator has been the face of obstruction inside the DEA's Diversion Control Division, using his signature to delay, deny, and destroy federally compliant scientific research-including the case of MMJ BioPharma Cultivation, which has been blocked from developing pharmaceutical-grade cannabis for over 2,300 days.
But now, documents from the DEA's own internal guidance-Sections 5202.5 and 5201.12 of the Diversion Control Manual-expose a truth that Prevoznik either doesn't understand or is deliberately ignoring:
The DEA is required to support bona fide Schedule I research, expedite applications, and allow legitimate brokers to process international shipments without registering as importers.
Yet under DEA's direction, the DEA has done exactly the opposite.
Section 5202.5: The DEA Policy Prevoznik Pretends Doesn't Exist
Let's review what the DEA's own policy says:
"DEA Fully Supports Bona Fide Research Utilizing Schedule I Controlled Substances For legitimate purposes."
"DEA works closely with the FDA and the National Institute of Health to ensure that research applications are approved expeditiously."
"Every effort should be made to expedite any applications for schedule I research from legitimate individuals."
So why did the DEA deny MMJ BioPharma's Corrective Action Plan without offering any path forward?
Why has the DEA:
Delayed MMJ's cannabis manufacturing registration for 7 years?
Forced unconstitutional ALJ hearings?
Refused to recognize FDA orphan drug designations?
Sabotaged legitimate research despite a clear mandate to "expedite" it?
Either the diversion administrators were sleeping in school, skipped this section of the manual-or he's actively violating it.
Section 5201.12: The International Hypocrisy
DEA's blockade doesn't stop at domestic research. In an absurd twist of hypocrisy, the DEA allows international corporations to export and import Schedule I substances using unregistered brokers, as long as a DEA-registered entity is involved.
Per Section 5201.12:
"A controlled substance import/export broker who handles paperwork and makes shipping arrangements, but does not take possession, is not required to register with the DEA."
So why is the DEA targeting companies like MMJ BioPharma Cultivation, which have followed every step of the law, while ignoring large recreational marijuana firms illegally shipping Schedule I substances overseas?
The answer is clear: this isn't about compliance. It's about bias, control and corruption.
DEA 's Real Mission: Delay, Not Diversion
While DEA's published mission is to "ensure an adequate and uninterrupted supply" of controlled substances for medical and scientific needs, Prevoznik has twisted that mandate into a blockade.
The DEA is:
Violating federal law including the Medical Marijuana and Cannabidiol Research Expansion Act
Ignoring President Trump's Right to Try Act
Defying Supreme Court precedent by pushing unconstitutional ALJs
And sabotaging lawful, FDA-aligned companies like MMJ BioPharma
This isn't just unethical. It's a direct betrayal of the DEA's own rulebook.
The DEA Administrator Must Send His Diversion Agents Back to School-or Out the Door
As DEA Administrator nominee Terry Cole prepares to take the reins, he must make a choice: allow bureaucratic sabotage to continue, or restore the agency's credibility by enforcing the policies already in writing.
That means:
Terminating agent's role in cannabis and psilocybin oversight
Auditing all denied Schedule I research applications since 2018
Restoring MMJ BioPharma's registration rights
Enforcing DEA's own internal policies as written in 5202.5 and 5201.12
Because the only thing more dangerous than violating the law is violating it while pretending you're upholding it.
Time to Graduate from the DEA Obstruction Schoolhouse
DEA Diversion and the cast of clowns has had two decades to learn how to administer the DEA's mission. Instead, he's rewritten it behind closed doors, with zero transparency, and at the expense of patients, science, and federal law.
DEA DIVERSION ADMINISTRATOR's -start by reading the manual.
And then do us all a favor:
Step aside.
Start with Section 5202.5.
Then read 5201.12.
And then, resign.
Because no agency can lead while being led by someone who doesn't follow their own manual.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
MHisey@mmjih.com
203-231-8583
SOURCE: MMJ International Holdings
Source: MMJ International Holdings
Related Media